WILMINGTON, MA--(Marketwire -12/21/11)- Implant Sciences Corporation (OTCQB: IMSC.PK - News) (Pinksheets: IMSC.PK - News), a high technology supplier of systems and sensors for homeland security markets, announced today that its recently launched Quantum Sniffer™ QS-B220 benchtop explosives and narcotics trace detector has received CE certification. The CE testing process evaluates the safety and performance of products against the harmonized standards defined by the 27 member nations of the European Union (EU).
"Since nearly all customers in Europe require CE certification, this is a key to opening up the European market for our QS-B220. It will also support our efforts outside of the EU, as buyers in many nations look to CE certification as a guide for quality and safety in their own markets," stated Bruce Bower, Implant Sciences' Senior Vice President of Sales and Marketing.
"This is a significant milestone for Implant Sciences and for our QS-B220. Europe is a substantial market for us, where we have established distribution channels already selling our QS-H150 handheld portable explosives trace detector," stated Glenn D. Bolduc, President and CEO of Implant Sciences. "With CE certification, we can immediately leverage these distribution channels to offer our benchtop model. Meeting CE standards also satisfies several requirements mandated by the U.S. Transportation Security Administration."
The QS-B220 benchtop explosives and narcotics trace detector is well suited for a variety of security settings, including high-traffic airports and borders. The system is currently being evaluated by security organizations around the world.
About the Quantum Sniffer™ QS-H150
The QS-H150 is a handheld explosives trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives. The QS-H150 uses no radioactive materials and features a low-maintenance design that is self-calibrating and self-clearing, providing very high levels of operational availability.
About the Quantum Sniffer™ QS-B220
The QS-B220, introduced in May 2011, is a benchtop explosives and narcotics trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives, plus narcotic substances. The QS-B220 continues the Implant Sciences tradition of freedom from radioactive materials, low total cost of ownership, and high operational availability.
About Implant Sciences
Implant Sciences develops, manufactures, and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed innovative proprietary technologies used in its explosives and narcotics trace detection systems, which ship to a growing number of locations domestically and internationally. Implant Sciences products have been deployed in a wide range of security environments including airports, subways, railways, cargo facilities, nuclear power plants, police departments, military units, government buildings, and financial institutions. The QS-H150 and QS-B220 are Department of Homeland Security (DHS) Qualified Anti-Terrorism Technologies under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at www.implantsciences.com.
Safe Harbor Statement
This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by the Transportation Security Administration or by other U.S. or foreign government and law enforcement agencies or commercial consumers of security products; economic, political and other risks associated with international sales and operations could adversely affect our sales; our business is subject to intense competition and rapid technological change; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including our most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.